Inferior Outcome With Addition Of Rituximab For Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Acute Lymphoblastic Leukemia (ALL)
P. Kebriaei, M. Munsell, K. Gutierrez, M. de Lima, S. Giralt, C. Hosing, U. Popat, M.H. Qazilbash, D. Thomas, H. Kantarjian, I.F. Khouri, R.E. ChamplinVolume:
15
Year:
2009
Language:
english
DOI:
10.1016/j.bbmt.2008.12.361
File:
PDF, 66 KB
english, 2009